The Cerebrospinal Fluid in Multiple Sclerosis.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 22 11 2018
accepted: 18 03 2019
entrez: 30 4 2019
pubmed: 30 4 2019
medline: 11 8 2020
Statut: epublish

Résumé

Investigation of cerebrospinal fluid (CSF) in the diagnostic work-up in suspected multiple sclerosis (MS) patients has regained attention in the latest version of the diagnostic criteria due to its good diagnostic accuracy and increasing issues with misdiagnosis of MS based on over interpretation of neuroimaging results. The hallmark of MS-specific changes in CSF is the detection of oligoclonal bands (OCB) which occur in the vast majority of MS patients. Lack of OCB has a very high negative predictive value indicating a red flag during the diagnostic work-up, and alternative diagnoses should be considered in such patients. Additional molecules of CSF can help to support the diagnosis of MS, improve the differential diagnosis of MS subtypes and predict the course of the disease, thus selecting the optimal therapy for each patient.

Identifiants

pubmed: 31031747
doi: 10.3389/fimmu.2019.00726
pmc: PMC6473053
doi:

Substances chimiques

Aquaporin 4 0
Biomarkers 0
Neurofilament Proteins 0
Oligoclonal Bands 0
neurofilament protein L 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

726

Références

J Neuroimmunol. 2000 Aug 1;108(1-2):207-15
pubmed: 10900355
Ann Neurol. 2001 Jul;50(1):121-7
pubmed: 11456302
Mult Scler. 2001 Dec;7(6):359-63
pubmed: 11795456
Neurology. 2002 Mar 12;58(5):824-6
pubmed: 11889253
Neurology. 2002 Aug 27;59(4):555-9
pubmed: 12196648
Ann Neurol. 2003 Feb;53(2):222-6
pubmed: 12557289
J Neuroimmunol. 2003 Jul;140(1-2):198-209
pubmed: 12864990
J Immunol. 2004 Jan 1;172(1):661-8
pubmed: 14688379
Eur J Neurol. 2004 Jan;11(1):37-42
pubmed: 14692886
Neurology. 2003 Dec 23;61(12):1720-5
pubmed: 14694036
J Neurol. 2004 Apr;251(4):414-20
pubmed: 15083285
Eur J Neurol. 2004 Aug;11(8):525-9
pubmed: 15272896
J Neurol. 2004 Oct;251(10):1278-9
pubmed: 15503113
J Neurol. 2005 Feb;252(2):146-50
pubmed: 15729518
J Neurol. 2005 Apr;252(4):396-402
pubmed: 15778816
J Clin Invest. 2005 May;115(5):1352-60
pubmed: 15841210
N Engl J Med. 2005 Jul 28;353(4):369-74
pubmed: 15947079
Arch Neurol. 2005 Jun;62(6):865-70
pubmed: 15956157
Eur J Neurol. 2005 Jul;12(7):527-30
pubmed: 15958092
Brain. 2006 Jan;129(Pt 1):200-11
pubmed: 16280350
Ann Neurol. 2005 Dec;58(6):840-6
pubmed: 16283615
J Neurol Neurosurg Psychiatry. 2006 Aug;77(8):953-5
pubmed: 16574727
J Neuroimmunol. 2006 Jun;175(1-2):176-82
pubmed: 16626811
Mult Scler. 2006 Apr;12(2):143-8
pubmed: 16629417
J Neuroimmunol. 2006 Nov;180(1-2):17-28
pubmed: 16945427
Eur J Neurol. 2007 Aug;14(8):907-11
pubmed: 17662013
Arch Neurol. 2007 Oct;64(10):1407-15
pubmed: 17698695
J Neurol. 2008 Jul;255(7):1023-31
pubmed: 18535872
Neurology. 2009 Apr 14;72(15):1322-9
pubmed: 19365053
Mult Scler. 2010 Mar;16(3):287-92
pubmed: 20086018
Acta Neurol Scand. 2010 Dec;122(6):409-13
pubmed: 20175758
Brain. 2010 Apr;133(Pt 4):1082-93
pubmed: 20237129
Mult Scler. 2011 Mar;17(3):335-43
pubmed: 21135023
Mult Scler. 2011 May;17(5):521-31
pubmed: 21159721
J Neurol. 2011 May;258(5):882-8
pubmed: 21197541
Ann Neurol. 2011 Jan;69(1):83-9
pubmed: 21280078
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
J Neurol Sci. 2011 Jun 15;305(1-2):1-10
pubmed: 21463872
J Neurol Sci. 2011 Jul 15;306(1-2):82-90
pubmed: 21550068
Ann Neurol. 2011 Sep;70(3):520; author reply 521
pubmed: 21710627
Arch Neurol. 2011 Jul;68(7):913-7
pubmed: 21747031
Lancet Neurol. 2011 Aug;10(8):745-58
pubmed: 21777829
Neuroimmunomodulation. 2012;19(2):96-102
pubmed: 22248725
Mult Scler. 2012 Aug;18(8):1081-91
pubmed: 22252467
Neurology. 2012 Jun 12;78(24):1986-91
pubmed: 22581930
J Neuroinflammation. 2012 Sep 14;9:215
pubmed: 22978757
J Neuroimmunol. 2013 Jan 15;254(1-2):146-53
pubmed: 23026221
J Proteome Res. 2013 Mar 1;12(3):1101-7
pubmed: 23339689
J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):909-14
pubmed: 23431079
Mult Scler. 2014 Jan;20(1):43-50
pubmed: 23702432
Acta Neurol Scand. 2013 Dec;128(6):e33-6
pubmed: 23763388
J Neuroimmunol. 2013 Sep 15;262(1-2):113-20
pubmed: 23870535
J Neuroimmunol. 2013 Sep 15;262(1-2):1-10
pubmed: 23890808
PLoS One. 2013 Nov 05;8(11):e79649
pubmed: 24223985
J Neurol Sci. 1986 Aug;75(1):33-42
pubmed: 2427659
J Neuroimmunol. 2014 Apr 15;269(1-2):87-9
pubmed: 24582001
Ann Neurol. 2014 Dec;76(6):792-801
pubmed: 24729444
Clin Chem Lab Med. 2014 Sep;52(9):1335-40
pubmed: 24731954
Mol Diagn Ther. 2014 Dec;18(6):605-17
pubmed: 25164543
J Neurol. 2014 Dec;261(12):2338-43
pubmed: 25228004
Mult Scler. 2015 Jul;21(8):1013-24
pubmed: 25680984
Ann Neurol. 2015 Jul;78(1):3-20
pubmed: 25808056
Neurology. 2015 Apr 21;84(16):1639-43
pubmed: 25809304
Clin Chem Lab Med. 2016 Feb;54(2):285-92
pubmed: 26079822
Mult Scler. 2016 Apr;22(4):502-10
pubmed: 26199348
Eur J Neurol. 2016 Apr;23(4):713-21
pubmed: 26806360
Mol Cell Proteomics. 2016 Apr;15(4):1360-80
pubmed: 26831522
EBioMedicine. 2015 Nov 22;3:135-140
pubmed: 26870824
Lancet Neurol. 2016 Jun;15(7):673-684
pubmed: 27068280
Curr Opin Neurol. 2016 Jun;29(3):254-62
pubmed: 27075495
Neurology. 2016 Sep 27;87(13):1393-9
pubmed: 27581217
Nervenarzt. 2016 Dec;87(12):1300-1304
pubmed: 27730274
J Neuroinflammation. 2016 Sep 27;13(1):280
pubmed: 27793206
Expert Rev Mol Diagn. 2017 Jan;17(1):31-46
pubmed: 27911122
Mult Scler Relat Disord. 2017 Feb;12:59-63
pubmed: 28283109
Ann Neurol. 2017 Jun;81(6):857-870
pubmed: 28512753
Lancet. 1987 Jan 3;1(8523):1-4
pubmed: 2879090
Clin Chem. 2017 Dec;63(12):1856-1865
pubmed: 29021324
Mult Scler. 2017 Oct;23(12):1600-1613
pubmed: 29041870
Acta Neurol Scand. 2017 Nov;136 Suppl 201:34-36
pubmed: 29068490
Neurology. 2017 Nov 28;89(22):2230-2237
pubmed: 29079686
Expert Rev Clin Immunol. 2017 Dec;13(12):1143-1153
pubmed: 29090607
Handb Clin Neurol. 2017;146:285-296
pubmed: 29110776
Handb Clin Neurol. 2017;146:67-84
pubmed: 29110780
Immunol Res. 2017 Dec;65(6):1103-1109
pubmed: 29116612
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
J Neurol. 1987 Jan;234(1):19-22
pubmed: 2950211
Ann Neurol. 2018 Apr;83(4):739-755
pubmed: 29518260
Front Immunol. 2018 Apr 04;9:557
pubmed: 29670611
J Neuroinflammation. 2018 May 3;15(1):134
pubmed: 29724224
Mult Scler. 2018 May 1;:1352458518774880
pubmed: 29775134
Degener Neurol Neuromuscul Dis. 2017 Sep 28;7:109-125
pubmed: 30050382
J Neurol. 2018 Oct;265(10):2342-2345
pubmed: 30109480
Nat Rev Neurol. 2018 Oct;14(10):577-589
pubmed: 30171200
Neuropsychiatr Dis Treat. 2018 Sep 03;14:2241-2254
pubmed: 30214214
Autoimmun Rev. 2019 Jan;18(1):43-49
pubmed: 30408586
Eur J Neurol. 2019 Apr;26(4):566-e41
pubmed: 30629326
Acta Neurol Scand. 2019 May;139(5):422-427
pubmed: 30657162
Eur Neurol. 1985;24(1):16-22
pubmed: 3967672
Acta Neurol Scand. 1967;43:Suppl 28:1-136
pubmed: 4167871
J Neurol. 1994 Dec;242(1):26-36
pubmed: 7897449
J Neurol Sci. 1994 Apr;122(2):189-203
pubmed: 8021703
J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):897-902
pubmed: 8057110
Ann Neurol. 1997 Mar;41(3):326-33
pubmed: 9066353
Neurology. 1998 Mar;50(3):708-14
pubmed: 9521261

Auteurs

Florian Deisenhammer (F)

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

Henrik Zetterberg (H)

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Department of Neurodegenerative Disease, UCL Institute of Neurology, London, United Kingdom.
The Fluid Biomarker Laboratory, UK Dementia Research Institute at UCL, London, United Kingdom.

Brit Fitzner (B)

Division of Neuroimmunology, Department of Neurology, University Medicine Rostock, Rostock, Germany.

Uwe K Zettl (UK)

Division of Neuroimmunology, Department of Neurology, University Medicine Rostock, Rostock, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH